Switzerland· 68396009
Sitagliptin Metformin Spirig HC 50/850 mg, Filmtabletten
A metformin and sitagliptin product containing sitagliptinum, metformini hydrochloridum, registered in Switzerland by Spirig HealthCare AG and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Metformin and sitagliptin is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BD07 (metformin and sitagliptin), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 9 of them publish a price we can compare per daily dose
Metformin and sitagliptin · ATC A10BD07
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- sitagliptinum, metformini hydrochloridum
- Manufacturer
- Spirig HealthCare AG
- Country
- Switzerland (CH)
- ATC code
- A10BD07
- ATC class
- Metformin and sitagliptin
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680683960094Ds 196 StkCHF 52.6
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin and sitagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and sitagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and sitagliptin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANSIFORA DUOVipharm S.A., Ożarów Mazowiecki
- SpainDISIMET 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Alter S.A.
- PolandAnsifora DuoVipharm S.A.
- NetherlandsEfficib 50 mg/1000 mg, filmomhulde tablettenMerck Sharp & Dohme B.V.
- United StatesJANUMETMerck Sharp & Dohme LLC
- SwedenEfficib 50 mg/1000 mg Filmdragerad tablettMerck Sharp & Dohme BV
- FinlandBrandasitGenepharm S.A.
- ItalyADIABINPHARMEXTRACTA S.P.A.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Jamesi, Jansitin Duo
- Belgium · Sitagliptin/Metformin Grindeks, Sitagliptin/Metformin Sandoz
- Bulgaria · Jansitin Duo, Metlinka 50 Mg/1000 Mg
- Cyprus · Diabremet, Jivolar
- Czechia · Ansifora Duo, Asigefort
- Germany · Metformax Combi, Metsunix
- Denmark · Glerova, Sitagliptin/Metformin "sandoz"
- Estonia · Asigefort, Diabremet
- Spain · Disimet, Estequen
- Finland · Brandasit, Sitagliptin/Metformin Glenmark
- France · Sitagliptine/Chlorhydrate De Metformine Micro Labs, Sitagliptine/Chlorhydrate De Metformine Olpha
- United Kingdom (Northern Ireland) · Sitagliptin / Metformin Hydrochloride Macleods, Sitagliptin / Metformin Hydrochloride Macleods Pharma Uk
- Greece · Brandasit, Co-Fineria
- Croatia · Condias Combi, Eprocliv
- Hungary · Ansifora Duo, Asigefort
- Ireland · Sitagliptin And Metformin Hydrochloride Ascend, Sitagliptin/Metformin Clonmel
- Iceland · Aps, Efficib
- Italy · Adiabin, Diesmit
- Liechtenstein · Efficib, Janumet
- Lithuania · Asigefort, Eprocliv
- Latvia · Asigefort, Eprocliv
- Malta · Combodiab Galenicum Health, Diabremet
- Netherlands · Eprocliv, Fordiab
- Norway · Efficib, Janumet
- Poland · Ansifora Duo, Asigefort
- Portugal · Jivolar, Metformina + Sitagliptina Alter
- Romania · Eprocliv, Jamesi
- Sweden · Jivolar, Mifomet
- Slovenia · Eprocliv, Jivolar
- Slovakia · Ansifora Duo, Asigefort
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9e16c3d-6ec7-4d06-95b5-0755dbf11881 GET /v1/drugs/a9e16c3d-6ec7-4d06-95b5-0755dbf11881?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "sitagliptinum 50 mg + metformini hydrochloridum 850 mg",
"valid_from": "2024-11-01",
"limitations": "[{\"description\":\"Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, welche mit Diät und gesteigerter körperlicher Aktivität und den bisherigen oralen Therapien und/oder Insulin nur ungenügend eingestellt werden können oder diese nicht vertragen.<br>\\n- Wenn weder mit Metformin noch mit Sitagliptin als Monotherapie eine ausreichende Kontrolle der Glykämie erreicht wird, oder bei Patienten, die bereits eine Kombination von Sitagliptin und Metformin erhalten.<br>\\n- Als Dreifachkombination in Kombination mit einem Sulfonylharnstoff, wenn durch eine Kombination von zwei der drei folgenden Wirkstoffe keine ausreichende Kontrolle der Glykämie erreicht wird: Metformin, Sitagliptin oder ein Sulfonylharnstoff.<br>\\n- In Kombination mit Insulin, wenn durch diese Massnahme keine ausreichende Kontrolle der Glykämie erreicht wird. <br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"priceModel\":null,\"validFrom\":\"2023-02-01\"}]",
"galenic_form": "Filmtabl 50/850mg",
"therapeutic_area": null,
"sl_inclusion_date": "2024-11-01",
"self_retention_pct": 10
}See everything about metformin and sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.